Education is an important part of the MSG mission statement: Education - Championing excellence and innovation in the development and delivery of evidence-based medical knowledge in invasive fungal disease management for patients globally.  The MSGERC sets an annual educational agenda based on current evidence in mycology and collaborates with the Education Committee and educational consultants to organize a variety of shared learning activities that meet the learning needs of infectious disease specialists, adult and pediatric internists, pharmacists, health care practitioners, and researchers. MSGERC educational offerings may range from high-level international forums, “air lifted” educational conferences and symposia and enduring activities providing web-accessible continuing medical education. These programs are generally for practitioners aiming to provide the best prevention, diagnosis and treatment of invasive fungal infections in normal and immunocompromised patient populations.

CDC and CHAI Advanced HIV Disease 
Global ECHO Webinar Series:

Advanced HIV Disease in the context 
of the COVID-19 pandemic in Africa

with support from the CDC Mycotic Disease Branch and the Clinton Health Access Initiative

Join us for our next session: 

Histoplasmosis, a neglected killer

Wednesday, December 9
US: 6:30 am PST, 7:30 am MST, 8:30 am CST, 9:30 am EST 
AFRICA: 2:30 pm GMT, 3:30 pm WAT, 4:30 pm CAT/SAST, 5:30 pm EAT

Time Zone Adjustment
French and Spanish translation provided


Click HERE to register

Objectives for continuing sessions

  1. Evidence driven advocacy targeted at MOH decision makers, academics, donors and implementing partners to prioritize continued AHD programming and service delivery in the time of COVID-19
  2. Contribute to training and continuing medical education for AHD during the pandemic
  3. Provide key AHD updates to continue to support field implementation

Click HERE to register


Jointly provided by Postgraduate Institute for Medicine; Terranova Medica, LLC; and the Mycoses Study Group Education & Research Consortium.

This activity is supported by an independent educational grant from F2G.

ID in Motion

The YouTube channel “ID in Motion” is now online.

A first video has been posted and we will post more every ten days, five more videos are already shot, four cut, and we continue to tape more videos diligently.  Please take a look at

You can also follow @CornelyOliver via Twitter, where new videos will be announced every 10 days!

Mycosis in the COVID Era
Monthly Virtual Meetings - June - September 2020
Meetings are presented in Spanish

These meetings are organized by the IMEMA committee in conjunction with the Argentine Association for Microbiology. More than 200 attended the session in June and more than 280 attended the session in July. MSGERC members, Dr. Tom Chiller (June) and Dr. Luis Ostrosky (July) were invited speakers. Recorded session are available here.

Upcoming Topics
August HIV - COVID and Mycoses 

September Endemic Mycoses and COVID

The New Antifungal Toolkit 2019

We invite you to participate in the latest toolkit update: The New Antifungal Toolkit 2019: Review of Itraconazole Formulations and Application in Endemic Mycoses. In the first section, Dr Russell Lewis and Dr Dimitrios P. Kontoyiannia provide an overview of conventional itraconazole capsules as well as the IV formulation. They then review the profile of SUBA-itraconazole, an itraconazole formulation with enhanced bioavailability that recently became commercially available in the United States. In the second section, Dr George Thompson provides an update on endemic mycoses, including a discussion of the place for SUBA-itraconazole in therapy. We hope you find this toolkit helpful in your care of patients with invasive fungal infections who are candidates for itraconazole therapy.

Registration and Information

Learning Objectives
At the conclusion of this activity, the participants will be better able to:

  • Compare and contrast newly FDA-approved and emerging antifungal agents/formulations with established antifungal therapeutics
  • Evaluate factors affecting the bioavailability of antifungal agents and their impact on efficacy/safety
  • Provide appropriate treatment for endemic fungi

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, PhD Hon, FECMM, FAAM
Russell E. Lewis, PharmD, FCCP, BCPS
George R. Thompson III, MD, FACP

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Doctor Fungus Website

The DrFungus website was launched in the early 2000s and featured at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 2001.  The original website was spearheaded by Dr John Rex and a team of collaborators from 3 continents and a dedicated web designer.  Over the last decade, the site became dormant.  In 2016 MSGERC relaunched the website under a new design and branding.  With the initial sponsorship by Astellas, the site is publicly available at  This website features key updated encyclopedic features of the original site and includes Case of the Month.   To submit a case of the month, contact Peter G. Pappas, MD 

MSGERC Biennial Meeting

The MSGERC hosts a conference every two years whereby the fungal "state of the science" is presented by key opinion leaders in pre-clinical, veterinary, clinical areas.  The MSGERC Biennial Meeting provides an opportunity to generate new research concepts to address current and emerging unmet needs.  During this meeting academic investigators, junior investigators/fellows, private infectious disease practitioners, industry and government members join together for these common aims. 

MSGERC Education Initiatives

The Mycoses Study Group Education and Research Consortium (MSGERC) builds on its thirty-eight year legacy of scientific and academic expertise in mycology to collectively understand the needs of healthcare professionals in the field of mycology, institutions and companies worldwide. These include, but are not limited to the following:

  • Maintaining the desired level of expertise in a wide range of topics related to pre-clinical and clinical applications in mycology
  • Staying abreast of all cutting edge trends in mycology research for the prevention, diagnosis and disease management globally
  • Working endlessly to diagnose, treat and alleviate invasive fungal infections
  • Working to educate providers with state-of-the-art methods for treating invasive fungal infections

The MSGERC works with infectious disease key opinion leaders who have a broad range of expertise in a wide variety of patient populations, including oncology, rheumatology, pediatrics, HIV, and tropical medicine.  During its Biennial Meeting, the MSGERC invites key opinion leaders to present current pre-clinical, genomic, epidemiologic and clinical lectures addressing Endemic Mycoses, Cryptococcosis, Candidiasis, and Aspergillosis.  Each set of lectures is followed by facilitated discussions.  Video-taped lectures are featured on the MSGERC Youtube channel, Doctor Fungus website, and CDC Websites to disseminate information and learning opportunities.


The MSGERC works in tandem with key CME providers Terranova Medica, LLC  and University of Nebraska Center of Continuing Education, School of Medicine.

Many CMEs are currently available at the MSGERC Continuing Education Portal


The MSGERC has disseminated findings from its multiple studies and activities through presentations at meetings and publications in peer-reviewed journals and book chapters.  A list of MSG Publications can be accessed on the Scholarship page.

Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines 

Upcoming Meetings of Interest

For your convenience, we have listed upcoming meetings for 2020-2021.  You may see some of our members on the agenda.

 INFOCUS  October 17 and October 24, 2020 Online
 ID Week  October 21 - 25, 2020 Online
 Federation of Infection Societies  November 9 - 11, 2020 Online
 International Immunocompromised Host Society  January 31 - February 2, 2021 Melbourne, Australia
 MSGERC  May 18 - 21, 2021 Albuquerque, New  Mexico
 ASM Microbe  June 3 – 7, 2021
Anaheim, California
 International Conference on Cryptococcus & Cryptococcosis  June 7 - 11, 2021

Speke Resort Munyoyo
Kampala, Uganda

 Trends in Medical Mycology  October 8 - 11, 2021 Aberdeen, Scotland, United Kingdom

Important Links

In addition to our long-standing commitment to generating educational outreach, MSG-member scholarly activities continue to contribute to awareness and education of mycology topics and treatment guidelines globally, including:


MSGERC Education Committee Members

George Thompson, MD, Chair (US)

John Baddley, MD, Co-Chair (US)

Ilan Schwartz- Co-Chair, Social Media (US)

Joe Vazquez- Co-Chair, Case of the Month (US)

Peter Pappas, MD- Co-Chair, Biennial Meeting, Patient Advocacy

Other Members:

Barbara Alexander, MD (US)

David Andes, MD (US)

David Boulware (US)

Oliver Cornely, MD (DRG)

Dimitrios Kontoyiannis, MD (US)

Bart-Jan Kullberg, MD (NL)

Luis Ostrosky-Zeichner, MD (US)

Tom Patterson, MD (US)

John Perfect, MD (US)

Marisa Micheli, MD (US)

Monica Slavin, MD (AU)

Carolynn Thomas Jones, DNP, MSPH, RN, (MSGERC Executive Director) (US)

Alisa Peinhardt, MAIS, RN (MSGERC Clinical Operations Director) (US)

Lisa Tushla, PhD (Educational Consultant)

Tom Davis (Educational Consultant)

Last Updated 9/9/19

(412) 344-2437

MSGERC Privacy Policy   

Powered by Wild Apricot Membership Software